|
| |
Elixir Pharmaceuticals, Inc Pages on BioPortfolio:
BioPortfolio - Elixir Pharmaceuticals, Inc
Elixir Pharmaceuticals, Inc - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/22424-Elixir_Pharma...
|
Biotechnology News Tinnitus tinnitu. merz. neramexan. tbf ...
Elixir Pharmaceuticals, Inc., announced today positive results from a pivotal phase III clinical study of the Companys oral formulation of mitiglinide ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - BioPortfolio - Elixir Pharmaceuticals, Inc
BioPortfolio - Elixir Pharmaceuticals, Inc - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/22424/www.e...
|
Biotechnology News Fatty Liver haukeland. nafld. metformin ...
Elixir Pharmaceuticals, Inc., announced today positive results from a pivotal phase ... (BUSINESS WIRE)--November 19, 2008--Elixir Pharmaceuticals, Inc., ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Chapter 1.r1
Elixir Pharmaceuticals. Michael D. Webb. Chief Executive Officer. EPIX Medical, Inc. Larry Wellman. Vice President, Human Resources. Digene Corporation ...
http://www.bioportfolio.com/pdf/Biotechnology_Management_Pra...
|
Biotechnology News new drug application NDA elixir. mitiglinid ...
Barr Pharmaceuticals Inc. (BRL: News ), announced that its subsidiary Barr Laboratories, Inc., has initiated a challenge of the patent listed by Anesta in
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Biocorporate Search Cambridge
Elixir Pharmaceuticals, Inc. We are a biopharmaceutical company utilizing aging research to develop pharmaceuticals that treat and/or prevent metabolic ...
http://www.bioportfolio.com/biocorporate/search/city/Cambrid...
|
Biotechnology News Iron Deficiency Anemia amag. saumyadeb. esha ...
(Recasts, adds details) Nov 19 (Reuters) - Elixir Pharmaceuticals Inc said a late-stage trial of its oral formulation for diabetes met the main goal of the
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Signal Pharmaceuticals - Profile
Signal Pharmaceuticals Inc, 5555 Overlin Drive, San Diego, CA 92121, USA.- IDrugs. 1998 ... Elixir reports positive results from Phase III diabetes trial
...
http://www.bioportfolio.com/biocorporate/9537-Signal%2BPharm...
|
Biotechnology News Hemoglobin Search
Elixir Pharmaceuticals, a developer of novel pharmaceuticals for the treatment of metabolic diseases, ... 19 /PRNewswire/ -- BioTrends Research Group, Inc. ...
http://www.bioportfolio.co.uk/Hemoglobin-news.htm...
|
Results from other life science and pharmaceutical sites:
BioCentury - Elixir Pharmaceuticals Inc. - Company Profile
Elixir Pharmaceuticals Inc. Completed. 11/28/2006. Venture (Series C financing). $31000000. Elixir Pharmaceuticals Inc. Completed. 11/28/2006 ...
http://www.biocentury.com/companies/Elixir_Pharmaceuticals_I...
|
BioPortfolio - Elixir Pharmaceuticals, Inc
Elixir Pharmaceuticals, Inc - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/22424-Elixir_Pharma...
|
BioCentury - Baxter International Inc. - Company Profile
Business Category, Pharmaceuticals. Year Founded, 1931 ... to ROI™ are trademarks of BioCentury Publications, Inc., P.O. Box 1246 San Carlos, CA 94070.
...
http://www.biocentury.com/companies/Baxter_International_Inc...
|
Elixir Pharmaceuticals Plans $86.25 Million IPO - News, Search ...
24 Sep 2007 ... (BUSINESS WIRE)--Elixir Pharmaceuticals, Inc. announced today that it has filed a registration statement with the Securities and Exchange ...
http://www.biospace.com/news_story.aspx?NewsEntityId=70736...
|
Elixir Pharmaceuticals Phase III Trial of Metformin-Mitiglinide ...
(BUSINESS WIRE)--Elixir Pharmaceuticals, Inc., announced today positive results from a pivotal phase III clinical study of the Company’s oral formulation of ...
http://biz.yahoo.com/bw/081119/20081119005243.html?.v=1...
|
Elixir Pharmaceuticals and Siena Biotech S.p.A. enter Agreement to ...
Elixir Pharmaceuticals, Inc. and Siena Biotech S.p.A. announced today that the two. companies have entered into an agreement to collaborate on the ...
http://www.sienabiotech.com/news/news_download.jsp?news_id=1...
|
BioSpace - Elixir Pharmaceuticals News, Search Jobs, Events
Elixir Pharmaceuticals' Phase III Trial of Metformin-Mitiglinide Combination Therapy Demonstrates ... 2008 BioSpace, Inc - an onTargetjobs company ...
http://www.biospace.com/company_profile.aspx?CompanyId=54071...
|
Elixir Extends IP Surrounding SirT Deacetylases with Exclusive ...
December 16, 2004 - Elixir Pharmaceuticals, Inc. announced today. that it has secured an exclusive license to intellectual property from the Regents of the
...
http://www.gladstone.ucsf.edu/gladstone/files/publicaffairs/...
|
Elixir Pharmaceuticals Sees IPO of 5 Million Shares at $14-$16 ...
Dec 18 (Reuters) - Elixir Pharmaceuticals Inc, a company focused on drugs for metabolic diseases like diabetes and obesity, registered its initial public ...
http://www.biospace.com/news_story.aspx?NewsEntityId=80816...
|
Genentech's Desmond-Hellmann and Stanford's Professor Weissman ...
... Inc., Active Pass Pharmaceuticals Inc., Acumen Pharmaceuticals Inc., ... Cyternex, diaDexus, Inc., Elitra Pharmaceuticals, Elixir Pharmaceuticals, Inc.,
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
|
